Skip to content

Latest

NACDS opens registration for 2014 Annual Meeting

The National Association of Chain Drug Stores has begun registration for the 2014 NACDS Annual Meeting. NACDS said Friday that online registration for the event, to be held April 26 to 29, 2014, in Scottsdale, Ariz., is available on the association’s website at annual.NACDS.org.

Pharmaca rolls out Natural Beauty Bar to more stores

Pharmaca Integrative Pharmacy Inc. has brought its Natural Beauty Bar services, launched a year ago, to another five locations. Pharmaca said Thursday that it now offers the Natural Beauty Bar in its Brentwood, Menlo Park, Novato and Oakland, Calif., stores and in its Portland, Ore., store.

Jean Coutu Group no longer a Rite Aid stakeholder

Jean Coutu Group no longer a Rite Aid stakeholder

The Jean Coutu Group has sold its remaining shares of Rite Aid Corp., divesting its equity stake in the U.S. drug chain. Jean Coutu Group said that on Thursday it completed the sale of 65,401,162 shares of Rite Aid common stock for $192.2 million (U.S.), which will result in a $94.1 million

Taro names new chairman, CEO

Taro Pharmaceutical Industries Ltd. has announced senior leadership changes, including the appointment of a new chairman and a new chief executive officer. The company said Thursday that Dilip Shanghvi has been named chairman of the board and that, effective Aug.

UrinoZinc expands retail distribution

Prostate health formula UrinoZinc has added to its product line available at Walmart. Vitanergy Inc., maker of the dietary supplement for men, said Wednesday that UrinoZinc Plus with Beta-Sitosterol is now available at almost all Walmart stores, which also carry UrinoZinc Prostate Formula.

Sales at Shoppers Drug Mart climb in 2Q

Shoppers Drug Mart Corp. saw revenue and same-store sales rise in the second quarter of 2013, while earnings topped analysts’ forecast by a penny. Canada’s largest drug chain reported the positive results just days after announcing a blockbuster deal to be acquired by Loblaw Cos. for $12.

Mylan releases Nor-Q.D. generic

Mylan Inc. has launched norethindrone tablets 0.35 mg, a birth control pill. The company reported Tuesday that its partner, Famy Care Ltd., received final approval from the Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for the product. product Mylan Inc.